| MYC regulates the antitumor immune response through CD47 and PD-L1 SC Casey, L Tong, Y Li, R Do, S Walz, KN Fitzgerald, AM Gouw, V Baylot, ... Science 352 (6282), 227-231, 2016 | 1268 | 2016 |
| Global levels of histone modifications predict prostate cancer recurrence J Ellinger, P Kahl, J Von Der Gathen, S Rogenhofer, LC Heukamp, ... The Prostate 70 (1), 61-69, 2010 | 255 | 2010 |
| Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen I Gütgemann, AM Fahrer, JD Altman, MM Davis, Y Chien Immunity 8 (6), 667-673, 1998 | 255 | 1998 |
| A population of murine γδ T cells that recognize an inducible MHC class Ib molecule MP Crowley, AM Fahrer, N Baumgarth, J Hampl, I Gutgemann, L Teyton, ... Science 287 (5451), 314-316, 2000 | 226 | 2000 |
| Argyrin A reveals a critical role for the tumor suppressor protein p27kip1 in mediating antitumor activities in response to proteasome inhibition I Nickeleit, S Zender, F Sasse, R Geffers, G Brandes, I Sörensen, ... Cancer cell 14 (1), 23-35, 2008 | 222 | 2008 |
| Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma MA Patil, I Gütgemann, J Zhang, C Ho, ST Cheung, D Ginzinger, R Li, ... Carcinogenesis 26 (12), 2050-2057, 2005 | 157 | 2005 |
| Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model A Morales-Kastresana, MF Sanmamed, I Rodriguez, A Palazon, ... Clinical Cancer Research 19 (22), 6151-6162, 2013 | 155 | 2013 |
| Tumor necrosis factor alpha-and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable … D Engel, U Dobrindt, A Tittel, P Peters, J Maurer, I Gütgemann, ... Infection and immunity 74 (11), 6100-6107, 2006 | 126 | 2006 |
| Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma V Seitz, P Butzhammer, B Hirsch, J Hecht, I Gütgemann, A Ehlers, ... PloS one 6 (11), e26837, 2011 | 125 | 2011 |
| H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 … C Magerl, J Ellinger, T Braunschweig, E Kremmer, LK Koch, T Höller, ... Human pathology 41 (2), 181-189, 2010 | 116 | 2010 |
| Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis NB Leimkühler, HFE Gleitz, L Ronghui, IAM Snoeren, SNR Fuchs, ... Cell stem cell 28 (4), 637-652. e8, 2021 | 112 | 2021 |
| Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms D Niebel, J Kirfel, V Janzen, T Höller, M Majores, I Gütgemann Blood, The Journal of the American Society of Hematology 124 (1), 151-152, 2014 | 105 | 2014 |
| Transforming Growth Factor β1 Regulates Tissue Inhibitor of Metalloproteinases—1 Expression in Differentiated Human Articular Chondrocytes M Günther, HD Haubeck, E Van De Leur, J Bläser, S Bender, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1994 | 101 | 1994 |
| Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2) Up-regulation by interleukin-6 and transforming growth factor β1 T Kordula, I Güttgemann, S Rose-John, E Roeb, A Osthues, H Tschesche, ... FEBS letters 313 (2), 143-147, 1992 | 76 | 1992 |
| Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI AH Penner, AM Sprinkart, GM Kukuk, I Gütgemann, J Gieseke, HH Schild, ... European radiology 23, 2773-2783, 2013 | 74 | 2013 |
| Gene expression profiling identifies new biological markers of neoplastic germ cells K Biermann, LC Heukamp, K Steger, H Zhou, FE Franke, I Guetgemann, ... Anticancer research 27 (5A), 3091-3100, 2007 | 74 | 2007 |
| Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. C Beeson, J Rabinowitz, K Tate, I Gütgemann, YH Chien, PP Jones, ... The Journal of experimental medicine 184 (2), 777-782, 1996 | 72 | 1996 |
| Stem cell marker expression in small cell lung carcinoma and developing lung tissue LK Koch, H Zhou, J Ellinger, K Biermann, T Höller, A von Rücker, ... Human pathology 39 (11), 1597-1605, 2008 | 68 | 2008 |
| Prognostic profiling of the immune cell microenvironment in Ewing s Sarcoma Family of Tumors D Stahl, AJ Gentles, R Thiele, I Gütgemann Oncoimmunology 8 (12), e1674113, 2019 | 65 | 2019 |
| Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation D Tormo, A Ferrer, E Gaffal, J Wenzel, E Basner-Tschakarjan, J Steitz, ... The American journal of pathology 169 (2), 665-672, 2006 | 65 | 2006 |
